Table 1.
Hospitalization in COVID-19 confirmed institutionalized patients over 64 years of age.
| Global (N = 4,632) | No hospitalization (N = 2,860) | Hospitalization (N = 1,772) | p | |
|---|---|---|---|---|
| Sex | <0.001* | |||
| Male | 1,621 (35.00%) | 865 (30.24%) | 756 (42.66%) | |
| Female | 3,011 (65.00%) | 1,995 (69.76%) | 1,016 (57.34%) | |
| Age | 0.058 | |||
| 65–79 | 760 (16.41%) | 493 (17.24%) | 267 (15.07%) | |
| ≥80 | 3,872 (83.59%) | 2,367 (82.76%) | 1,505 (84.93%) | |
| Socioeconomic level | <0.001* | |||
| Mutualist | 160 (3.45%) | 121 (4.23%) | 39 (2.20%) | |
| Pensioner <18,000€/year | 3,639 (78.56%) | 2,260 (79.02%) | 1,379 (77.82%) | |
| Pensioner ≥ 18,000€/year | 611 (13.19%) | 337 (11.78%) | 274 (15.46%) | |
| Free medicines | 184 (3.97%) | 114 (3.99%) | 70 (3.95%) | |
| Other | 38 (0.82%) | 28 (0.98%) | 10 (0.56%) | |
| Number of diseases (a) | 6.00 (4.00; 8.00) | 6.00 (4.00; 8.00) | 6.00 (5.00; 8.00) | <0.001* |
| Complexity (a) | 3.00 (2.00; 4.00) | 3.00 (2.00; 4.00) | 3.00 (2.00; 4.00) | 0.003* |
| Diagnosis | ||||
| Diabetes mellitus | 1,166 (25.99%) | 668 (24.31%) | 498 (28.64%) | 0.001* |
| Obesity | 440 (9.50%) | 343 (12.48%) | 229 (13.17%) | 0.531 |
| Hypertension | 3,237 (72.14%) | 1,966 (71.54%) | 1,271 (73.09%) | 0.275 |
| Stroke | 654 (14.58%) | 382 (13.90%) | 272 (15.64%) | 0.117 |
| Ischemic heart disease | 460 (10.25%) | 254 (9.24%) | 206 (11.85%) | 0.006* |
| Heart failure | 578 (12.88%) | 321 (11.68%) | 257 (14.78%) | 0.003* |
| COPD | 453 (10.10%) | 243 (8.84%) | 210 (12.08%) | 0.001* |
| Chronic kidney disease | 1,258 (28.04%) | 716 (26.06%) | 542 (31.17%) | <0.001* |
| Depression | 1,269 (28.28%) | 771 (28.06%) | 498 (28.64%) | 0.699 |
| Dementia | 1,494 (33.30%) | 928 (33.77%) | 566 (32.55%) | 0.416 |
Sociodemographic and clinical characteristics.
N, number; p, statistical significance; a, results expressed as median and interquartile range; COPD, chronic obstructive pulmonary disease.
*Statistically significant results.